Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06935383
PHASE2

Randomised EValuation of Therapies for microvAscuLar Injury in STEACS

Sponsor: CorFlow Therapeutics AG

View on ClinicalTrials.gov

Summary

The goal of this interventional study is to evaluate if the CoFI system can act as a platform for intracoronary infusion of therapeutic agents to treat and relieve microvascular injury in ST Elevation Acute Coronary Syndrome (ACS) subjects diagnosed with MicroVascular Obstruction (MVO) after Primary Percutaneous Intervention (PPCI) and to quantify (identify) markers of treatment efficacy for CoFI mediated therapeutic agents infusion versus control. The targeted population is subjects presenting with an ST elevation myocardial infarction and undergoing PPCI as per standard of care. Enrolled STEMI subjects will be examined for MVO with the CoFI system. Primary endpoint of the study is EF by TTE at 6 months. If detected with MVO with the CoFI system, the subjects will be randomized and will receive treatment with medicinal product(s).

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

250

Start Date

2025-09

Completion Date

2027-09

Last Updated

2025-04-20

Healthy Volunteers

No

Interventions

DEVICE

Therapeutic sequence

the required dose of treatment is administered through the CoFI system

DEVICE

Diagnostic sequence

Diagnostic sequence to detect MVO